Drug intelligence / Profile preview

avobenzone + oxybenzone + ecamsule + octocrylene + homosalate + octisalate + octinoxate aerosol spray

Development stage
Unknown
Lead developer
U.S. Food & Drug Administration
Modality
Small Molecules
Administration
Topical
01

Overview

This refers to an aerosol spray sunscreen formulation containing a combination of chemical UV filters, including avobenzone, oxybenzone, ecamsule, octocrylene, homosalate, octisalate, and octinoxate. It was evaluated by the U.S. Food and Drug Administration (FDA) in a Phase 1 maximal usage trial (MUsT), specifically NCT03582215, to investigate the systemic absorption and pharmacokinetics of these active ingredients when applied under conditions of high-volume topical use. These ingredients function as sunscreen agents by absorbing ultraviolet (UV) radiation, thereby protecting the skin from sunburn and long-term damage such as photoaging and skin cancer. The study aimed to determine if plasma concentrations of these filters exceed the FDA's safety threshold of 0.5 ng/mL, which would trigger further nonclinical safety assessments.

Other names
Aerosol Spray-Food and Drug Administration (FDA)-sunburnFDA MUsT Aerosol SpraySunscreen Aerosol Spray (NCT03582215)

Beyond the preview

Go deeper on avobenzone + oxybenzone + ecamsule + octocrylene + homosalate + octisalate + octinoxate aerosol spray.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on avobenzone + oxybenzone + ecamsule + octocrylene + homosalate + octisalate + octinoxate aerosol spray.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call